Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

from Urology Times Podcasts · host Urology Times

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

Episode metadata supplied by the publisher feed · Published Sep 7, 2021

Embed this episode

Attribution link and audio player

What this episode covers

In this episode, Urology Times® Managing Editor Ben Saylor spoke with Amy E. Krambeck, MD. She discusses the recent Journal of Endourology study, "Multi-institutional prospective randomized control trial of novel intracorporeal lithotripters: ShockPulse-SE vs Trilogy trial," for which she served as senior author. Krambeck is a professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

0:00 5:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Urology Times Podcasts?

This episode is 5 minutes long.

When was this Urology Times Podcasts episode published?

This episode was published on September 7, 2021.

Can I download this Urology Times Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!